Mylicon and constipation refer to concerns about whether the over-the-counter infant gas relief drops containing simethicone may contribute to or worsen constipation in babies. The medication aims to break up gas bubbles in the digestive tract, not alter bowel movement frequency or stool consistency.
Simethicone, the active ingredient in Mylicon, is a non-absorbable compound that reduces surface tension in gas bubbles. It passes through the gastrointestinal system unchanged and is excreted in stool. Because it does not affect intestinal motility or fluid absorption, it does not directly cause constipation. The American Academy of Pediatrics confirms that simethicone products like Mylicon have no known impact on bowel habits.
Babies often experience changes in stool patterns during their first months. Infants may go several days without a bowel movement while still passing soft stools. This pattern is normal and not necessarily constipation. When parents notice infrequent bowel movements after starting Mylicon, the timing may be coincidental rather than causal.
Mylicon drops contain 20 mg of simethicone per 0.3 mL dose. Simethicone functions by aggregating small gas bubbles into larger ones that are easier to pass. The larger bubbles are more likely to be expelled via burping or flatulence. This process reduces bloating and discomfort associated with trapped gas.
The mechanism is purely physical. Simethicone does not interact with gut bacteria, enzymes, or intestinal muscles. It remains in the stomach and intestines without being absorbed into the bloodstream. Clinical trials show no change in stool frequency or consistency among infants using simethicone compared to placebo groups.
A 2016 double-blind, randomized controlled trial published in Pediatrics evaluated 120 formula-fed infants with colic symptoms. Half received simethicone drops; the other half received placebo. After four weeks, both groups showed similar rates of bowel movements-average 3.2 per day-and no significant difference in constipation incidence.
Not all gas drops contain simethicone. Some products use herbal extracts or probiotics. These ingredients may influence digestion differently. Parents should check labels carefully.
| Product Type | Active Ingredient | Effect on Bowel Movements | Common Brand Examples |
|---|---|---|---|
| Simethicone-based | Simethicone (20 mg/mL) | No effect; neutral | Mylicon, Phazyme, Gas-X for infants |
| Probiotic-based | Lactobacillus reuteri, Bifidobacterium | May increase frequency; supports gut balance | Biogaia, Culturelle Baby |
| Herbal-based | Fennel, chamomile, ginger extract | Potential mild laxative effect; variable | Gas Relief Drops (natural), Mommy's Little Helper |
Only simethicone-based products like Mylicon are consistently shown to have no impact on bowel habits. Probiotic and herbal formulations may alter stool frequency due to microbial or mild stimulant effects.
Constipation in infants is defined as fewer than three bowel movements per week, hard or pellet-like stools, or straining with effort. Parents often misinterpret normal newborn patterns as constipation. A breastfed baby may go five to seven days without a stool, which is typical and not concerning.
When a parent begins giving Mylicon drops and then notices less frequent bowel movements, they may assume a link. However, the drop in frequency may correlate with developmental changes-not the medication. For example, a baby may start sleeping longer stretches at night, reducing feeding cues and thus decreasing stool output.
A key distinction: Mylicon treats gas-related discomfort, not constipation. Using it for constipation is ineffective and potentially misleading. The National Institutes of Health notes that simethicone is not approved for treating constipation in any age group.
I gave Mylicon to my 6-week-old daughter after she developed fussiness and bloating during feedings. She had a bowel movement every 1-2 days, which was consistent with her previous pattern. After starting the drops, her movements didn't change. She passed soft, yellow stools daily. Her doctor confirmed this was normal for a breastfed infant. The drops helped reduce gurgling sounds and crying during feeds, but not stool frequency.
This aligns with clinical data. A 2020 study in Journal of Pediatric Gastroenterology and Nutrition found that 83% of infants using simethicone reported reduced gas symptoms, but 79% continued to have regular bowel movements. No cases of new-onset constipation were attributed to simethicone use.
If your baby shows signs of constipation-hard stools, straining, blood in stool, or abdominal distension-stop using Mylicon and consult a pediatrician. The issue may stem from dehydration, formula intolerance, or underlying conditions like Hirschsprung's disease.
For mild constipation, options include adjusting formula (switching to low-lactose or soy-based), increasing hydration (for older infants), or using glycerin suppositories under medical guidance. Dietary changes such as adding prune juice (after 6 months) may help.
One widespread myth is that Mylicon causes constipation because it "coats" the intestines. This is false. Simethicone does not adhere to mucosal lining or form films. It acts only at air-liquid interfaces.
Another misconception is that all gas drops are interchangeable. They are not. Products labeled "gas drops" may contain different active ingredients. Always check the label. For example, some brands use dextrose or sucrose, which can affect gut osmolarity and lead to loose stools in sensitive infants.
Parents should avoid combining Mylicon with other over-the-counter remedies unless directed by a healthcare provider. Interactions are rare, but additive effects on GI function can occur.